glp 1 for iih Novel use of GLP-1 receptor agonist therapy pediatric idiopathic intracranial hypertension: a case report Exenatide (a GLP-1 receptor agonist)
Pay in 4 interest-free payments of $6.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
Exenatide (a GLP 1 receptor agonist) rapidly lowered intracranial pressure in active IIH, with a sustained signal at 12 weeks and no meaningful weight change. The authors suggest an ICP lowering The effect of GLP 1 agonist on idiopathic intracranial hypertension: a systematic review and meta analysis Jamal Ahmad, Ahmed Mohamed Hamdy, Bahaa Elfakharany, Muhammad M. Elsharkawy, Mohamed El Samahy, Mazen Momtaz Shehata, Elsayed S. Impact of GLP 1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity matched multi institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals Excited to share our study @JAMANeuro GLP 1 RA therapy for idiopathic intracranial hypertension (IIH) was associated with fewer symptoms, less medication use, & fewer procedures vs conventional treatment, using the TriNetX database
Store: www.cleversources.com · Domain: www.cleversources.com
